Objective-Exposure to dioxins has been shown to contribute to the development of inflammatory diseases, such as atherosclerosis. Macrophage-mediated inflammation is a critical event in the initiation of atherosclerosis. Previously, we showed that treatment of macrophages with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) leads to aryl hydrocarbon receptor ( 
pidemiological studies on a population heavily exposed to dioxin in 1976 in Seveso, Italy, indicate that coronary and hypertensive diseases have been increasing in recent years among the exposed population. 1 A more recent study confirms a higher incidence of hyperlipidemia, atherosclerotic plaques, increased intima-media thickness, and ischemic heart disease in a group of former dioxin workers. 2 These observations agree well with the results of experimental animal studies, 3, 4 as well as other epidemiological evidence from factory workers exposed to chlorinated organic compounds, 5 that these aryl hydrocarbon receptor (AhR) ligands indeed cause hyperlipidemia. Hyperlipidemia, particularly hypercholesterolemia, has been described to be associated with a significant reduction in binding of low-density lipoprotein (LDL) to its receptor on the hepatic plasma membrane observed in guinea pigs as a result of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment. 6 Dalton et al reported that TCDD promotes an earlier onset and greater severity of atherosclerotic lesions in apolipoprotein E (ApoE)Ϫ/Ϫ mice. 7 Their study provides further evidence that atherogenesis is a major risk factor for ischemic heart diseases that are known to develop in ApoEϪ/Ϫ mice as an end result of TCDD exposure and AhR activation.
See accompanying article on page 1247
Atherosclerosis is considered a chronic inflammatory disease of the vessel wall characterized by chemokine-driven mononuclear cell recruitment into the subendothelial space, where the mononuclear cells differentiate into macrophages. 8 These macrophages promote plaque development by secreting numerous inflammatory mediators, such as cytokines and chemokines, that sustain the inflammatory milieu, recruit leukocytes to the vascular wall, and regulate immune functions. All these functions make the plaque macrophage an interesting target for prevention and therapy of atherosclerotic disease.
Our previous studies have shown that air pollutants, such as urban dust particles or particles from diesel engine exhaust, as well as the prototypical AhR ligand TCDD, activate an inflammatory response in macrophages and may lead to the formation of foam cells. 9, 10 Another major risk factor for cardiovascular diseases is cigarette smoke, which contains many compounds that activate the AhR, such as polycyclic aromatic hydrocarbon (PAH). Thus, it is important to understand how pathological stimuli such as air pollutants may affect macrophage phenotype and function and how these mechanisms lead to atherosclerosis.
Interleukin (IL)-8 has been implicated as a contributing factor to atherosclerosis and has been considered to play a pivotal role in pathogenesis of vascular diseases. 11 Thus, increased expression of IL-8 was found to be associated with the presence of macrophage-derived foam cells in human atheroma. 12 Macrophages are considered a major source to contribute to overexpression of IL-8 in atherosclerotic tissue. Our previous studies show that the most consistently observed phenomenon accompanying induction of foam cell formation triggered by oxidized LDL, lipopolysaccharide, or TCDD in U937 macrophages is an early and sustained upregulation of IL-8. 10, 13 The discovery that IL-8 also acts as a mediator of cholesterol loading in macrophages makes IL-8 one of the most important players in atherogenesis. In this regard, it is interesting to learn that recently Gargalovic et al found that atherogenesis induced by oxidized phospholipids in endothelial cells can be attenuated by silencing the IL-8 pathway through the use of small interfering RNA (siRNA) technology. 14 CXCR2, a G protein-coupled receptor mediating chemotaxis in immune responses, is believed to play a key role in several inflammatory diseases, including atherosclerosis. CXCR2 is expressed in neutrophils, monocytes, and macrophages and binds several chemokines, including CXCL8 (IL-8), CXCL1 (GRO␣), and CXCL5. 15 CXCR2 has been shown to have a major impact on macrophage accumulation in advanced lesions. 16 Activation of the chemokine receptor CXCR2 enhances monocyte-endothelial adhesion and promotes angiogenesis by increasing vascular endothelial growth factor (VEGF) expression. 17, 18 Thus, IL-8 and its receptor CXCR2 appear to be among the essential players in this cell model of atherogenesis. CCR2 is a receptor for monocyte chemoattractant protein-1 (MCP-1), a chemokine that specifically mediates monocyte chemotaxis. In the current study, we investigated how chemokine receptors CXCR2 and CCR2 contribute to the development of atherosclerotic plaques mediated by AhR activation.
Methods
Cell Differentiation, Treatment, and Transient Small Interfering RNA Transfection U937 monocytic cells were treated with 12-O-tetradecanoylphorbol-13-acetate (3 g/mL) and allowed to adhere for 48 hours in a 5% CO 2 tissue culture incubator at 37°C, after which they were fed with 12-O-tetradecanoylphorbol-13-acetate-free medium to promote differentiation into macrophages.
Cigarette smoke extract (CSE) was prepared as described earlier. 19 Macrophages were treated for 24 hours with 10 nmol/L TCDD, 10% CSE, or 0.1% Me 2 SO as vehicle control in absence or presence of 10 mol/L AhR antagonist 3Ј-methoxy-4Јnitroflavone (MNF).
Transfection of small interfering RNA into U937 macrophages was performed via Nucleofector technology as previously described. 13 Twenty-four hours after transfection, cells were treated with 10 nmol/L TCDD, 10% CSE, or 0.1% Me 2 SO (control) for another 24 hours. The reduction of the target RNA was detected by quantitative real-time reverse transcription-polymerase chain reaction (PCR).
Quantitative Real-Time Reverse Transcription-PCR
The RNA isolation from macrophage cells was carried out using a high-pure-RNA isolation kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. For preparation of total RNA from the aortas of ApoEϪ/Ϫ mice, the frozen tissue samples were homogenized first in Trizol using a TissueLyser instrument (Qiagen). The RNA was extracted with chloroform and further purified with the RNA isolation kit. cDNA synthesis was performed as previously described. 13 Quantitative real-time PCR was run with a LightCycler instrument (Roche Diagnostics) using the Fast Real-Time SYBR Green PCR Kit (Qiagen). All PCR assays were performed in duplicate or triplicate. For quantification, data were analyzed with the LightCycler analysis software.
Measurement of Cholesterol
Cellular cholesterol and protein determinations were performed as described previously. 10 Free and esterified cholesterol (total cholesterol) was extracted directly from in situ macrophage monolayers in the cell culture dish. Cells were treated for 5 days with 10 nmol/L TCDD or 10% CSE in absence or presence of AhR antagonist MNF (10 mol/L), CCR2 inhibitor INCB3344 (10 mol/L), and CXCR2 inhibitor SB225002 (10 mol/L) before cholesterol measurement.
Cholesterol from mouse aortas was extracted by isopropyl alcohol:acetonitrile:water treatment followed by a derivatization reaction and was measured by gas chromatography-mass spectrometry as previously described. 20 
Animal Treatment and Immunohistochemistry
The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (publication no. 82-23, revised 1996) and was approved (Protocol #13165) by the University of California Davis Animal Use and Care committee.
Mice were fed a regular chow diet (diet no. 5001, LabDiet) or a high-fat diet (HFD) (diet no. D12079B, Research Diets, Inc.). ApoEϪ/Ϫ mice (Jackson Laboratory, Sacramento, CA) were pretreated with 5 mg/kg CXCR2 inhibitor SB220005 or AhR antagonist CH223191 for 24 hours before TCDD treatment and cotreatment with inhibitors plus TCDD. Control animals received an equal amount of corn oil (5 mL/kg) or inhibitor alone. Eight-week-old C57BL/6J and ApoEϪ/Ϫ mice received a single intraperitoneal injection of 15 g/kg TCDD and a weekly maintenance dose of 1 g/kg TCDD or 5 mg/kg SB225002/CH223191. If not otherwise stated, 8 animals from each group were killed at day 60, and organs were excised, weighed, quickly frozen in liquid nitrogen, and stored at Ϫ80°C for analysis. Aortas were cleaned and stripped of fat on the adventitia before being excised.
Aortas were processed in serial sections at 3 m and stained with hematoxylin/eosin (H&E). Additional aortic sections were used for immunohistochemistry. Immunohistochemical stains were used to detect matrix metalloproteinase (MMP)-12 (Santa Cruz Biotechnology, Santa Cruz, CA) and identify macrophages and foam cells. Briefly, endogenous peroxidase was blocked with 3% hydrogen peroxidase/methanol. Slides were incubated in fresh citrate buffer, pH 6.0, at 25°C for antigen retrieval. The primary antibodies were diluted in 0.5% phosphate-buffered saline and ovalbumin and incubated at room temperature overnight. Detection was performed using a biotinylated secondary antibody followed by the Avidin-BiotinPeroxidase Complete ABC kit (Vector Laboratories, Burlingame, CA) and developed with diaminobenzidine chromogen substrate.
Statistical Analysis
To detect fold differences in gene expression, all expression values were logarithm-transformed for analysis, with results expressed as backtransformed meansϮstandard deviations. Data were analyzed by 1-way ANOVA as appropriate. If statistical significance (PՅ0.05) was determined by ANOVA, the data were further analyzed by the Students-Newman-Keuls procedure to detect specific differences between treatments.
Results

Effect of CSE and TCDD on Expression of Inflammatory Genes in Macrophages
A number of proinflammatory genes play important roles in vascular inflammation and the development of atherosclerosis. Here, we investigated the effect of 2 environmental pollutants, CSE and TCDD, on proinflammatory marker genes in macrophages derived from U937 cells. We selected CSE because it is well known to contain AhR-activating components and to cause cardiovascular diseases including atherosclerosis. 21, 22 As shown in Figure 1A , TCDD significantly increased the expression of IL-8, MCP-1, and MMP-12 by 13-fold, 6-fold, and 18-fold, respectively. The expression of the chemokine CXCL5, which is coregulated with IL-8, was increased approximately 3-fold by TCDD. Treatment with 10% CSE also increased the mRNA level of IL-8, CXCL5, MCP-1, and MMP-12, but the effect was less pronounced than after TCDD exposure. Increased expression of MMP-12 in atherosclerotic lesions has been shown to be associated with foam cell generation. 23 CYP1A1 gene expression was induced 33-and 8-fold by TCDD-and CSE-treated U937 macrophages, respectively ( Figure 1A ). To test whether the effects of TCDD and CSE are mediated through AhR signaling, cells were cotreated with CSE or TCDD in the presence of AhR antagonist MNF. As expected, TCDD-induced target genes were significantly suppressed by MNF significantly by Ϸ80% to 90%. CSE-induced target genes were suppressed by MNF to a lesser degree (Ϸ50%).
Induction of VEGF mRNA Expression in U937 Macrophages by TCDD Is AhR and IL-8 Dependent
VEGF has been described as a downstream target of CXCR2 activation. 18 To test whether CXCR2 signaling is stimulated by TCDD, the expression of VEGF was analyzed. The results in Supplemental Figure I (available online at http://atvb.ahajournals. org) show that silencing of AhR and IL-8 decreased their mRNA level specifically by 70% and 75%, respectively. As shown in Figure 1B , suppression of AhR and IL-8 expression through gene silencing decreased the TCDD-stimulated induction of VEGF, indicating that this effect is AhR dependent and mediated through IL-8, which binds to and activates CXCR2. CSE-induced expression of VEGF was also inhibited by AhR antagonist MNF (data not shown). The expression of CYP1A1 was analyzed as a control and found to be suppressed after transient transfection with siRNA targeting the AhR (siAhR), but not after silencing IL-8 ( Figure 1C) .
Stimulation of Cholesterol Accumulation in U937 Macrophages by TCDD and CSE
Foam cells are primarily macrophages laden with cholesterol ester-rich cytoplasmic lipid inclusions. To quantify the total amount of cholesterol in U937 macrophages, we used a colorimetric method in the presence of cholesterol oxidase and cholesterol esterase. Exposure of U937 macrophages for 5 days to 10% CSE or 10 nmol/L TCDD resulted in the accumulation of cholesterol by 1.8-and 2.1-fold, respectively ( Figure 1D ). To test whether the effect of CSE and TCDD exposure on cholesterol accumulation is AhR dependent and involves the chemokine receptors CCR2 or CXCR2, cells were treated with CSE and TCDD in the presence of MNF (10 mol/L), INCB3344 (10 mol/L), or SB225002 (10 mol/L), respectively. INCB3344, kindly provided by Pfizer, is a potent and selective small molecule antagonist of the mouse CCR2 receptor. INCB3344 inhibits CCL2-mediated functional responses, such as extracellular signal regulated kinase phosphorylation and chemotaxis. 24 SB225002 is a potent and selective CXCR2 chemokine receptor antagonist and prevents IL-8-induced neutrophil chemotaxis in vitro and sequestration in vivo. 25 Results from a cholesterol assay show that AhR-antagonist MNF, as well as the CXCR2 antagonist SB225002, efficiently blocked CSE-and TCDD-stimulated cholesterol accumulation. On the other hand, the CCR2 antagonist INCB3344 did not decrease the accumulation of cholesterol in CSE-and TCDD-treated cells ( Figure 1D ). These data suggest that CXCR2 signaling is involved in CSE-and TCDDstimulated cholesterol accumulation.
TCDD Promotes the Development of Atherosclerotic Lesions in ApoE؊/؊ Mice
In vivo effects of TCDD on the formation of atherosclerotic plaques were studied in ApoEϪ/Ϫ mice. As expected, no lesions were observed in C57BL/6 wild-type control ( Figure  2A and Supplemental Figure IIA Figure 1A ) and aortas of ApoEϪ/Ϫ after TCDD treatment (Table) . To examine whether macrophages are present in early atherosclerotic lesions, aorta sections were stained with a MMP-12 specific antibody. As shown in Figure 2G and Supplemental Figure IIG , expression of MMP-12 was not detectable in 3-month-old ApoEϪ/Ϫ mice fed a regular diet. In contrast, treatment with TCDD for 40 days resulted in the expression of MMP-12 in macrophages and macrophage-derived foam cells appearing in early atherosclerotic lesions ( Figure 2H and Supplemental Figure IIH) .
To test the contribution of AhR activation by TCDD on the formation of atherosclerotic lesion induced through HFD, mice were fed a Western diet for a period of 60 days after treatment with a single injection of 15 g/kg TCDD. The hearts and aortas were excised from the mice to examine the extent of atherosclerosis in the aortas. Representative examples of the aorta arches are shown in Figure 3A to 3D. The development of atherosclerotic lesions with mainly intracellular lipid accumulation occurred in ApoEϪ/Ϫ control mice fed an HFD ( Figure 3A and 3B and Supplemental Figure IIIA and IIIB). Furthermore, the area of atherosclerotic lesion with extensive lipid accumulation and a large lipid core in the serial sections of the aortic arches was advanced in TCDDtreated ApoEϪ/Ϫ mice, which were also fed an HFD ( Figure  3C and 3D and Supplemental Figure IIIC and IIID) .
In accordance with the in vitro findings, we tested the effect of SB225002 for inhibition of CXRC2 in ApoEϪ/Ϫ mice that were fed a regular chow diet and treated with Figure 4D and Supplemental Figure IVD) .
To investigate the AhR-dependent effect in vivo, we cotreated mice with MNF, which antagonized the TCDD-and CSE-mediated effects in U937 macrophages (Figure 1) . However, experiments with MNF in vivo were not successful to block TCDD-induced CYP1A1 expression or the development of atherosclerotic lesions in ApoEϪ/Ϫ mice (data not shown). This result was unexpected because a previous report showed the successful inhibition of AhR-mediated induction of CYP1A1 by MNF in vivo. 26 One explanation is that MNF is metabolized more rapidly in vivo and not a suitable AhR antagonist for long-term treatment in vivo. On the other hand, CH223191 a structurally unrelated AhR antagonist was used, because it has been demonstrated to prevent toxic effects of TCDD in vivo. 27 CH223191 inhibited the TCDD-mediated induction of CYP1A1 by Ϸ40% in liver of TCDD-treated ApoEϪ/Ϫ mice (data not shown). Furthermore, the development of atherosclerotic lesions was reduced by cotreatment with CH223191 ( Figure 4H and Supplemental Figure IVH 
Assessment of Atherosclerosis
To quantify the lesion of the atherosclerotic plaques, a quantitative analysis of the amount of cholesterol accumu- lated in the aortas of the ApoEϪ/Ϫ mice was done via gas chromatography-mass spectrometry. The mean aorta cholesterol level of the TCDD-treated group was increased approximately 1.7-fold compared with the control group ( Figure 5 ). The concentrations of cholesterol found in mice treated with the CXCR2 inhibitor SB225002 or the AhR antagonist CH223191 were similar to those in control mice. Interestingly, in agreement with the in vitro macrophage model the TCDD-induced cholesterol level in aortas from mice cotreated with SB225002 was not increased compared with the control group and lower than that in mice treated with TCDD alone. Furthermore, TCDD did not increase the level of cholesterol in the aortas of mice cotreated with CH223191, suggesting that the development of atherosclerotic lesions is AhR dependent ( Figure 5 ).
Gene Expression Analysis in the Aorta Arch of ApoE؊/؊ Mice
The effects of TCDD were first analyzed in ApoEϪ/Ϫ mice exposed to regular chow. Results from mRNA analysis of the aortas of ApoEϪ/Ϫ mice showed a distinct increase in CXC chemokines KC (mouse orthologue of human IL-8) and CXCL5; both of these chemokines bind to and activate the receptor CXCR2 (homolog of human IL-8R). An increased level of the CC chemokine MCP-1 was also found. Besides CYP1A1, the greatest gene expression increase was found for MMP-12, which is considered an indicator of activated macrophages and foam cells. 23 Atherogenic marker genes P-selectin and F4/80 were also elevated. F4/80 is a specific cell surface marker of macrophages, and elevated levels of P-selectin imply the recruitment of macrophages/foam cells to the atherogenic site. In parallel, mRNA levels of the same marker genes were compared in ApoEϪ/Ϫ mice fed an HFD.
The mRNA levels of all marker genes, except CYP1A1, of these mice were further increased by TCDD exposure. Interestingly, the expression of the examined genes, again with the exception of CYP1A1, was increased in control ApoEϪ/Ϫ mice on an HFD compared with the control group of ApoEϪ/Ϫ mice on regular chow (Table) .
Discussion
Atherosclerosis is an inflammatory disease of the arterial wall characterized by monocytes entering the subendothelial space followed by differentiation into macrophages and the development of foam cells. We have shown previously that environmental pollutants, including TCDD, diesel engine exhaust, and urban dust, lead to an AhR-dependent elevated level of cholesterol in macrophages, which is associated with a dose-dependent increase in IL-8, as well as other inflammatory markers, including MCP-1 and COX-2, and the formation of foam cells. 9, 10 Here, we show that treatment of macrophages not only with TCDD but also with CSE led to increased expression of the chemokines IL-8, MCP-1, and foam cell markers, such as MMP-12, in an AhR-dependent manner. Treatment with CSE, similar to treatment with TCDD, led to an elevated level of cholesterol in macrophages, which could be suppressed by an AhR antagonist. Interestingly, an AhR-dependent lipid accumulation stimulated by TCDD and benzo(a)pyrene (B(a)P) has been shown to involve the induction of the Niemann-Pick type C1 protein in macrophages. 28 The current study shows that inhibition of the chemokine receptor CXCR2 but not CCR2 abolished the enhanced accumulation of cholesterol by both TCDD and CSE. This result agrees with previous findings reporting that progression of early atherosclerotic lesions still occurred in ApoE and CCR2 double-knockout mice on an atherogenic diet. 29 These data indicate that TCDD and CSE stimulate formation of foam cells in an AhR-dependent manner and that this effect is mediated by CXCR2 through an elevated level of IL-8. This hypothesis is supported by results showing that gene silencing of AhR and IL-8 suppressed the increase of VEGF, which is a downstream target of CXCR2 signaling. Furthermore, these data suggest that AhR is a critical mediator of activating macrophages and forming foam cells not only for TCDD but also for components of cigarette smoke. This supports a previous report showing that the increased risk of coronary heart disease induced by cigarette smoke does not correlate with the amount of tar, nicotine, or carbon monoxide but rather other components of CSE, such as B(a)P and other AhR-activating PAHs. 30 Similar to B(a)P, PAHs such as B[e]P may increase inflammation and plaque formation independently from the AhR. 31 This would explain the potency of cigarette smoke in promoting atherogenesis because cigarette smoke is a major source of exposure to PAHs. PAHs are also known to form DNA adducts, which must be considered as a contributing factor to the development of atherosclerotic plaques in humans. 32, 33 Inhibition of CXCR2 in vitro as well as in vivo in the ApoEϪ/Ϫ mice by SB225002 prevented macrophages from accumulating cholesterol and reduced the formation of aortic plaque in TCDD-treated mice. Several CXC chemokines, including IL-8, KC, and CXCL5, can bind to and activate CXCR2. Thus, there is a possibility that besides KC or IL-8, other chemokines, such as CXCL5, are responsible for the development of early atherosclerotic lesions. However, the TCDD-mediated increase of CXCL5 in U937 macrophages was relatively low compared with the clear induction of IL-8 or the induction of KC in ApoEϪ/Ϫ mice. Therefore, the effect of enhanced lesions in vivo is more likely to be mediated through KC than through the elevated level of CXCL5 observed in aortas of ApoEϪ/Ϫ mice. Furthermore, Figure 5 . TCDD increased the amount of cholesterol accumulated in the aorta. ApoEϪ/Ϫ mice were treated with TCDD for 60 days in the absence or presence of SB225002 or CH223191 as described in Figure 4 . The amount of cholesterol that accumulated in the aorta was measured via gas chromatographymass spectrometry from 5 animals in each group. Results were significantly different from vehicle control (*) or from TCDDtreated mice (**) as indicated (PϽ0.05).
mice cotreated with the AhR antagonist CH223191 accumulated less cholesterol and had smaller atherosclerotic lesions compared with TCDD-treated mice, supporting the concept that this process is AhR dependent.
The expression of genes analyzed in the aortas of ApoEϪ/Ϫ mice revealed that the selected inflammatory genes, especially KC and MMP-12, were significantly increased in ApoEϪ/Ϫ mice fed an HFD compared with ApoEϪ/Ϫ mice on regular chow. Previous reports indicate that the TCDD-and B(a)P-induced profile of proinflammatory factors in macrophages might be more complex and may involve transforming growth factor-␤, tumor necrosis factor-␣, and CCL-1. 31, 34, 35 The results from the current study indicate that activation of KC and MMP-12 is involved in the development of atherosclerosis mediated through an HFD. On the other hand, the mRNA level of CYP1A1 was not affected by the HFD in ApoEϪ/Ϫ mice compared with mice on regular chow, which suggests that CYP1A1 is unlikely to be a key player in the formation of early atherosclerotic lesions induced by an HFD. This is not a trivial point, because modified LDL has been found to bind to and activate the AhR followed by an AhR-mediated signaling such as CYP1A1 induction. 36 Other investigators have found that TCDD binds and disrupts the secondary and tertiary lipoprotein structure, which leads to a significant reduction in its ability to bind lipoprotein lipase. 37 The altered lipoprotein structure impairs the cellular uptake of LDL and very-low-density lipoprotein, leading to an increased accumulation of serum lipoproteins that could accelerate the development of coronary artery disease. The TCDD-induced changes in the structure of LDL and very-low-density lipoprotein were found to be different from other modified LDL or very-low-density lipoprotein, which may bind to and activate scavenger receptors. 37 In this study, TCDD was found to be physically associated with LDL particles in TCDD-treated ApoEϪ/Ϫ mice fed an HFD. 7 These findings suggest that LDL might also serve as a vehicle to deliver the compound to atherosclerotic lesions, which may lead to more severe atherosclerotic plaques when mice are fed an HFD. Although TCDD can physically associate with LDL, we found similar effects in vitro after treatment with CSE, which suggests that this mechanism is unlikely and that induction of proinflammatory stimuli is the more probable mechanism. CSE and components of CSE-like peroxynitrite 38 have been reported to be involved in oxidative modification of LDL, 39 -41 which can induce proinflammatory responses and promotion of atherosclerosis.
Data from the current study support the assumption showing an earlier onset and greater severity of atherosclerotic lesions induced by TCDD in ApoEϪ/Ϫ mice fed an HFD compared with a regular chow diet. The fact that there was an earlier onset of atherosclerotic lesions after 2 months of TCDD exposure and the formation of severe atheroma after 7 months of TCDD exposure without feeding an HFD is noteworthy. Although the lesions induced by TCDD exposure alone were smaller compared with mice treated with TCDD and HFD, the current data suggest that induction of an inflammatory response by TCDD is sufficient to cause accumulation of cholesterol and the formation of atherosclerotic lesions in ApoEϪ/Ϫ mice.
In summary, the results reported in this study suggest that activation of macrophage-mediated inflammation followed by accumulation of cholesterol is a potential target of AhRactivating pollutants, such as dioxin and cigarette smoke. Findings also include the identification of the important role that CXCR2 ligands KC and IL-8 play in atherogenesis induced by AhR activation and support the possibility that environmental pollutants like TCDD may trigger vascular inflammation by activating signaling pathways involved in inflammatory responses and atherosclerosis. Although the toxicity of AhR-activating environmental pollutants in regard to cardiovascular disease warrants further study, the implications of CXC chemokines and their receptors for human health could be significant.
